- Home
- CMMB vs LIQT Comparison
CMMB vs LIQT Comparison
Compare CMMB & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- LIQT
- Stock Information
- Founded
- CMMB 2004
- LIQT 2004
- Country
- CMMB Israel
- LIQT Denmark
- Employees
- CMMB N/A
- LIQT N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- LIQT Industrial Machinery/Components
- Sector
- CMMB Health Care
- LIQT Technology
- Exchange
- CMMB Nasdaq
- LIQT Nasdaq
- Market Cap
- CMMB 20.9M
- LIQT 13.9M
- IPO Year
- CMMB N/A
- LIQT N/A
- Fundamental
- Price
- CMMB $1.12
- LIQT $2.40
- Analyst Decision
- CMMB Strong Buy
- LIQT Strong Buy
- Analyst Count
- CMMB 3
- LIQT 2
- Target Price
- CMMB $5.67
- LIQT $5.58
- AVG Volume (30 Days)
- CMMB 154.2K
- LIQT 9.1K
- Earning Date
- CMMB 11-07-2024
- LIQT 11-07-2024
- Dividend Yield
- CMMB N/A
- LIQT N/A
- EPS Growth
- CMMB N/A
- LIQT N/A
- EPS
- CMMB N/A
- LIQT N/A
- Revenue
- CMMB N/A
- LIQT $17,720,520.00
- Revenue This Year
- CMMB N/A
- LIQT $5.96
- Revenue Next Year
- CMMB N/A
- LIQT $32.89
- P/E Ratio
- CMMB N/A
- LIQT N/A
- Revenue Growth
- CMMB N/A
- LIQT 8.53
- 52 Week Low
- CMMB $0.42
- LIQT $1.90
- 52 Week High
- CMMB $2.55
- LIQT $4.10
- Technical
- Relative Strength Index (RSI)
- CMMB 29.01
- LIQT 41.76
- Support Level
- CMMB $1.10
- LIQT $2.19
- Resistance Level
- CMMB $1.59
- LIQT $2.51
- Average True Range (ATR)
- CMMB 0.15
- LIQT 0.14
- MACD
- CMMB -0.05
- LIQT -0.06
- Stochastic Oscillator
- CMMB 5.87
- LIQT 19.55
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.